Pieris Pharmaceuticals Inc (PIRS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -66.072 | -25.403 | -21.821 | -18.035 | -30.255 | -35.378 | -26.723 | -36.585 |
Return on Equity (%) | -80.912 | -96.041 | -103.986 | -55.8 | -90.387 | -111.853 | -84.584 | -89.758 |
Return on Invested Capital (%) | -81.714 | -118.151 | -150.73 | -62.265 | -89.787 | -137.175 | -116.848 | -59.432 |
Operating Margin (%) | -388.218 | -65.456 | -93.007 | -55.034 | -126.406 | -145.579 | -128.473 | -57.33 |
Net Profit Margin (%) | -390.996 | -69.82 | -91.935 | -55.034 | -126.965 | -145.579 | -128.473 | -57.33 |
Book Value Per Share | 0.586 | 0.256 | 0.369 | 0.884 | 0.527 | 0.703 | 0.375 | 0.271 |
Earnings Per Share | -0.529 | -0.392 | -0.247 | -0.438 | -0.632 | -0.633 | -0.447 | -0.248 |
Cash Per Share | 0.682 | 0.841 | 0.691 | 1.071 | 1.196 | 1.63 | 0.519 | 0.176 |
Working Capital Per Share | 0.564 | 0.978 | 0.806 | 1.514 | 0.909 | 1.067 | 0.495 | 0.271 |
Operating Profit Per Share | 0.135 | 0.561 | 0.269 | 0.796 | 0.498 | 0.435 | 0.348 | 0.433 |
EBIT Per Share | -0.526 | -0.367 | -0.25 | -0.438 | -0.629 | -0.633 | -0.447 | -0.248 |
EBITDA Per Share | -0.526 | -0.367 | -0.25 | -0.438 | -0.629 | -0.633 | -0.447 | -0.248 |
Free Cash Flow Per Share | -0.524 | -0.357 | -0.237 | -0.407 | -0.621 | -0.653 | -0.464 | -0.265 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 43,06M | 45,02M | 54,15M | 55,21M | 56M | 72,22M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -680.94 | N/A | N/A | N/A | -9230.189 | N/A | N/A |
Net Profit Margin (%) | N/A | -680.94 | N/A | N/A | N/A | -9230.189 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 21,3M |
Ratio cours/bénéfice | -0,71 |
Ratio prix/ventes | 0,41 |
Ratio prix/liquidités | 1,01 |
Ratio prix/valeur comptable | 0,65 |
Rendement de dividende | - |
Actions en circulation | 1,32M |
Volume moyen (1 semaine) | 27,62k |
Volume moyen (1 mois) | 19,35k |
Variation sur 52 semaines | 3,59% |
Plus haut sur 52 semaines | 22,32 |
Plus bas sur 52 semaines | 6,20 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales